A Randomized Phase I Clinical Trial of HydroVax-YFV, a Novel Inativated Yellow Fever Vaccine

Information

  • Research Project
  • 10404272
  • ApplicationId
    10404272
  • Core Project Number
    U44AI145791
  • Full Project Number
    4U44AI145791-02
  • Serial Number
    145791
  • FOA Number
    PAR-18-632
  • Sub Project Id
  • Project Start Date
    7/1/2019 - 4 years ago
  • Project End Date
    6/30/2024 - 6 days from now
  • Program Officer Name
    DEMPSEY, WALLA L
  • Budget Start Date
    7/2/2021 - 2 years ago
  • Budget End Date
    6/30/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    7/2/2021 - 2 years ago
Organizations

A Randomized Phase I Clinical Trial of HydroVax-YFV, a Novel Inativated Yellow Fever Vaccine

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    U44
  • Administering IC
    AI
  • Application Type
    4
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    999652
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:999652\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZAI1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NAJIT TECHNOLOGIES, INC.
  • Organization Department
  • Organization DUNS
    147965243
  • Organization City
    Beaverton
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    970063448
  • Organization District
    UNITED STATES